Juvenile-Onset Recurrent Respiratory Papillomatosis: The Benefits of Quadrivalent Human Papillomavirus Vaccination Continue to Accrue
- PMID: 29136167
- DOI: 10.1093/infdis/jix499
Juvenile-Onset Recurrent Respiratory Papillomatosis: The Benefits of Quadrivalent Human Papillomavirus Vaccination Continue to Accrue
Keywords: Australia; HPV; juvenile-onset recurrent respiratory papillomatosis; vaccine.
Comment on
-
A Prospective Study of the Incidence of Juvenile-Onset Recurrent Respiratory Papillomatosis After Implementation of a National HPV Vaccination Program.J Infect Dis. 2018 Jan 4;217(2):208-212. doi: 10.1093/infdis/jix498. J Infect Dis. 2018. PMID: 29136168
Similar articles
-
A Prospective Study of the Incidence of Juvenile-Onset Recurrent Respiratory Papillomatosis After Implementation of a National HPV Vaccination Program.J Infect Dis. 2018 Jan 4;217(2):208-212. doi: 10.1093/infdis/jix498. J Infect Dis. 2018. PMID: 29136168
-
Multi-Year Effect of Human Papillomavirus Vaccination on Recurrent Respiratory Papillomatosis.Laryngoscope. 2020 Feb;130(2):442-447. doi: 10.1002/lary.27993. Epub 2019 Apr 8. Laryngoscope. 2020. PMID: 30963598
-
Human papillomavirus types causing recurrent respiratory papillomatosis in Zimbabwe.Int J Pediatr Otorhinolaryngol. 2019 Jan;116:147-152. doi: 10.1016/j.ijporl.2018.10.036. Epub 2018 Oct 26. Int J Pediatr Otorhinolaryngol. 2019. PMID: 30554686
-
The Efficacy of Human Papillomavirus Vaccination as an Adjuvant Therapy in Recurrent Respiratory Papillomatosis.Laryngoscope. 2023 Sep;133(9):2046-2054. doi: 10.1002/lary.30560. Epub 2023 Jan 18. Laryngoscope. 2023. PMID: 36651338 Free PMC article. Review.
-
Treatment With Quadrivalent Human Papillomavirus Vaccine for Juvenile-Onset Recurrent Respiratory Papillomatosis: Case Report and Review of the Literature.J Pediatric Infect Dis Soc. 2017 Nov 24;6(4):380-385. doi: 10.1093/jpids/pix063. J Pediatric Infect Dis Soc. 2017. PMID: 28992265 Review.
Cited by
-
Health Impact and Cost-Effectiveness of Implementing Gender-Neutral Vaccination With the 9-Valent Human Papillomavirus Vaccine in Belgium.Front Pharmacol. 2021 Apr 12;12:628434. doi: 10.3389/fphar.2021.628434. eCollection 2021. Front Pharmacol. 2021. PMID: 33912045 Free PMC article.
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Other Literature Sources